National and Kapodistrian University of Athens
Επίδραση της χορήγησης παράγοντα διέγερσης αποικιών κοκκιοκυττάρων σε ένα μοντέλο πειραματικά επαγώμενης οξείας ηπατικής βλάβης και ανεπάρκειας σε επίμυς
Abstract
dc:descriptionHepatic regeneration consists an important step of the procedure taking place following any hepatic injury. The administration of drugs and factors capable of initiating or accelerating the hepatocyte proliferation have been proven a considerably promising strategy in the management of the fulminant hepatic failure (FHF). The aim of this experimental protocol is the administration of granulocyte-colony stimulating factor (G-CSF) in a model of chemically induced FHF in rats, and the study of not only the hepatic injury and regeneration, but the survival also. The above could be determined by measuring serum biochemical parameters, ammonia blood levels and the histopathology findings from the liver and the secondarily induced hepatic encephalopathy. Materials and methods: Adults, made wistar rats weighting 220-270 gr each were used. Rats were administered three intraperitoneal injections of thioacetamide (TAA) at a dose of 400 mg/kg body weight, at 24 hr intervals. All TAA treated rats were injected intraperitoneally with either 0,9% sodium chloride (group I), or recombinant G-CSF (group II) at a dose of 150 μg/kg body weight, 2 hours after the second and third TAA injection. Animals from both groups were sacrificed at 6, 12 and 18 hrs following the third injection of TAA, and were examined and staged for neurological signs of hepatic encephalopathy. Results: The group I animals presented increased levels of AST and ALT hepatic enzymes but stable levels of ALP, compared to group II, at all times examined, following the third administration of TAA. Serum urea and blood ammonia levels were also increased in rats of group I. Liver histology showed centrilobular necrosis with heavy inflammatory infiltration consisted mainly of polymorphonuclear leukocytes. An increased degree of inflammation was observed in group I animals. Hepatic DNA biosynthesis and thymidine kinase activity were statistically significantly increased in rats of group II, compared to group I rats. The animal survival was determined 18 hours following the third TAA administration. In group I 25% of the animals survived, while in group II, 60%. By the same time, animals of group I presented with encephalopathy of stage 3 to 4, compared to stage 2 for the survived members of group II. Discussion: The above experimental model consists a reliable analogue of the human FHF and encephalopathy rG-CSF administration ameliorated the decreased survival of rats exposed to TAA, by decreasing hepatocellular injury and increasing hepatocyte proliferative capacity. A decrease in serum hepatic enzymes was also noted. The administration of rG-CSF in intact non hepatectomized or exposed to any toxicagent, failed to affect either DNA biosynthesis or thymidine kinase activity and was also unable to induce any mitotic activity on hepatocytes. rG-CSF enhances hepatocyte proliferation occurring after partial hepatectomy (PH) when the loss of hepatic tissue synchronizes the hepatocytes in the remaining liver to proliferate, but also in models of chemically induced liver injury, when liver necrosis and inflammation are prominent. G-CSF administration to acute liver failure (ALF) patients proved to be safe and effective in reversing the neutrophils defects, possible playing a role in the treatment of infections in these patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Retsou, Zoi
- Ρέτσου, Ζωή
Subjects
dc:subject × 17- Κυτταροκίνες
- Κοκκιοκύτταρα, Παράγοντας διέγερσης αποικιών
- Ηπατική ανεπάρκεια, Κεραυνοβόλος
- Ηπατική εγκεφαλοπάθεια
- Ηπατική αναγέννηση
- ΚΗΑ - επιβίωση
- Ηπατική βλάβη
- Cytocines
- Granulocyte - colony stimulating factor ( G-CSF)
- Fulminant hepatic failure
- Encephalopathy
- Hepatic regeneration
- Liver injuries
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18708